Lobular Metastatic Breast Cancer - Metastatic Breast Cancer Trial Talk

From the Experts

Invasive lobular breast cancer makes up about 10 to 15 percent of all breast cancers diagnosed in the U.S. Patients with this breast cancer subtype are organizing and advocating for more scientific research into how this cancer differs from the more common invasive ductal breast cancer and for clinical trials that focus on this subtype.

Below you will find links to the Lobular Breast Cancer Alliance; a feature story by Diane Mapes, a journalist and LBCA patient research advocate; published research on metastatic LBC; a Facebook group specifically for individuals with metastatic LBC; and two conference presentations on metastatic LBC.

Last Modified on March 15, 2021



for past articles or specific information.